Endothelial Dysfunction in Obese Children

NCT ID: NCT01461226

Last Updated: 2023-05-15

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

61 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-06-30

Study Completion Date

2013-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to objectify the effect of diet and exercise on early markers of atherosclerosis in obese children.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The favorable responses of combined treatment strategies, consisting of exercise training and proper diet change, for childhood and adolescent obesity on vascular health are poorly understood. The overall objective of this research project is to investigate the underlying pathophysiological mechanisms that mediate these beneficial effects.

Particularly, the following aims are set forth:

1. To establish the effect of a combined lifestyle intervention, i.e. an individualized exercise training and caloric restriction program, on vascular function (primary endpoint) and structure in a substantial population of obese adolescents.
2. To characterize causal pathways between obesity and endothelial dysfunction with focus on classical risk factors, oxidative and inflammatory stress, metabolic adaptations, bone marrow derived progenitor cells, and blood microparticles.

This research knowledge will be instrumental for risk stratification and clinical management aimed to improve endothelial function by limiting damage and reinforcing regenerative mechanisms in obese adolescents.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Atherosclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exercise training

Individualized and progressively increased supervised aerobic exercise program on a daily base (3-4hours per day, hypocaloric diet and psychological guidance

Group Type EXPERIMENTAL

Exercise training

Intervention Type BEHAVIORAL

Individualized and progressively increased supervised aerobic exercise program on a daily base (3-4hours per day, hypocaloric diet and psychological guidance

Usual Care

Nutritional assessment and dietary advice by general practitioner, promotion of sports activities

Group Type OTHER

Usual care

Intervention Type BEHAVIORAL

Nutritional assessment and dietary advice by general practitioner, promotion of sports activities

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Exercise training

Individualized and progressively increased supervised aerobic exercise program on a daily base (3-4hours per day, hypocaloric diet and psychological guidance

Intervention Type BEHAVIORAL

Usual care

Nutritional assessment and dietary advice by general practitioner, promotion of sports activities

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Younger than 16 yrs: BMI ≥97th sex and age specific BMI-percentile
* Older than 16 yrs: BMI ≥35 kg/m²

Exclusion Criteria

* Acute or chronic inflammatory process, use of non-steroidal anti- inflammatory drugs or immunosuppressive drugs. (including inhalation corticosteroids).
* Structural heart disease or other cardiac diseases.
* Active malignant hematological disease
Minimum Eligible Age

12 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zeepreventorium

OTHER

Sponsor Role collaborator

University Hospital, Antwerp

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Luc Bruyndonckx

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Viviane M Conraads, M.D., PhD

Role: PRINCIPAL_INVESTIGATOR

Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zeepreventorium

De Haan, , Belgium

Site Status

Dienst Cardiale Revalidatie, Cardiologie, Universitair Ziekenhuis Antwerpen

Edegem, , Belgium

Site Status

Dienst Pediatrie, Universitair Ziekenhuis Antwerpen

Edegem, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EC 11/11/100

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Body Weight and Vascular Function
NCT01675401 COMPLETED NA
BATokines as Biomarkers of Brown Fat in Humans
NCT05050240 ACTIVE_NOT_RECRUITING NA